The lectures on Clinical Translation of Stem Cells emphasize the scientific, clinical, regulatory, ethical, and social issues that should be addressed so that basic stem cell research is responsibly translated into appropriate clinical applications for treating patients. These lectures by multidisciplinary group of stem cell experts comprise researchers, clinicians, ethicists, and regulatory specialists who offer recommendations founded on general principles for scientific, clinical, and ethical conduct that should be followed by all translational stem cell researchers, clinician-scientists, and regulators in  this fascinating field described as the “next evolution of medical treatments.”.

The course comprises  clinical translational research involving products from human embryonic or other pluripotent stem cells, novel applications of fetal or somatic (adult) stem cells, and hematopoietic or other stem cells used for applications outside established standards of care. The  major areas of translational stem cell research covered are: (a) cell processing and manufacture; (b) preclinical studies; and (c) clinical research.